Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Erythroid Cell Research: 3D Chromatin, Transcription Factors and Beyond. | Int J Mol Sci | 2022 | 35682828 | PubTator, text mining | PubMed |
| The Emerging Roles of Long Non-Coding RNAs in Intellectual Disability and Related Neurodevelopmental Disorders. | Int J Mol Sci | 2022 | 35682796 | PubTator, text mining | PubMed |
| Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing. | Int J Mol Sci | 2022 | 35682629 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease. | Cells | 2022 | 35681538 | PubTator, text mining | PubMed |
| Heterogeneity of enhancers embodies shared and representative functional groups underlying developmental and cell type-specific gene regulation. | Gene | 2022 | 35680026 | PubTator, text mining | PubMed |
| Translating principles of precision medicine into speech-language pathology: Clinical trial of a proactive speech and language intervention for infants with classic galactosemia. | HGG Adv | 2022 | 35677809 | PubTator, text mining | PubMed |
| Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases. | Heliyon | 2022 | 35677416 | PubTator, text mining | PubMed |
| Combining SNP-to-gene linking strategies to identify disease genes and assess disease omnigenicity. | Nat Genet | 2022 | 35668300 | PubTator, text mining | PubMed |
| PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin. | Blood Adv | 2022 | 35667093 | PubTator, text mining | PubMed |
| Advantages and Limitations of Gene Therapy and Gene Editing for Friedreich's Ataxia. | Front Genome Ed | 2022 | 35663795 | PubTator, text mining | PubMed |
| Wnt Signaling in the Breast: From Development to Disease. | Front Cell Dev Biol | 2022 | 35663403 | PubTator, text mining | PubMed |
| TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis. | Front Endocrinol (Lausanne) | 2022 | 35663307 | PubTator, text mining | PubMed |
| Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia. | Front Genet | 2022 | 35656314 | PubTator, text mining | PubMed |
| Computationally designed hyperactive Cas9 enzymes. | Nat Commun | 2022 | 35641498 | PubTator, text mining | PubMed |
| Salubrinal induces fetal hemoglobin expression via the stress-signaling pathway in human sickle erythroid progenitors and sickle cell disease mice. | PLoS One | 2022 | 35639781 | PubTator, text mining | PubMed |
| Engineering the next generation of cell-based therapeutics. | Nat Rev Drug Discov | 2022 | 35637318 | PubTator, text mining | PubMed |
| Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease. | Pharmaceuticals (Basel) | 2022 | 35631417 | PubTator, text mining | PubMed |
| Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. | J Pers Med | 2022 | 35629192 | PubTator, text mining | PubMed |
| Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia. | Genes (Basel) | 2022 | 35627268 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of the Interaction of miRNAs and piRNAs with Human mRNA Genes Having di- and Trinucleotide Repeats. | Genes (Basel) | 2022 | 35627185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=39